The Latest Breaking News from BioNTech

Government deal with BioNTech paves way for early access to trials of personalised mRNA therapies

BioNTech SE has signed a deal with the UK government to enrol up to 10,000 patients in clinical trials by the end of 2030 for personalised cancer therapies, the German drug maker said.

Hong Kong residents have swamped clinics to get vaccinated against COVID-19 ahead of the expected reopening of the city's border with mainland China, which some people fear will bring a surge of infections to the financial hub.

Health care centers from Guangzhou to Shijiazhuang and Beijing are slammed amid surging infections and severe shortages of medical workers

BioNTech, which helped develop one of the early COVID-19 vaccinations, is working on a herpes simplex virus vaccine

China's Shanghai Fosun Pharmaceutical Group said users of its mobile health app in China can now register to take COVID-19 booster shots in Hong Kong using BioNTech's vaccine.

Berlin has sent its first batch of BioNTech COVID-19 vaccines to China to be administered initially to German expatriates, a German government spokesperson said on Wednesday, the first foreign coronavirus vaccine to be delivered to the country.

China and Germany should work together to foster good relations between Beijing and the European Union without any interference by a third party, President Xi Jinping told Germany's president in a phone call on Tuesday, state media reported.

Officials and global health experts outside China are anxiously watching a COVID-19 surge there, worried a nation of 1.4 billion people is inadequately vaccinated and may not have the healthcare tools to treat a wave of illness expected to kill more than one million people through 2023.